TELA Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 1.21K shares, a 87.25% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 37.22K shares, a 275.12% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 38.43K shares, a 51.14% increase from fiscal 2023.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 25.43K shares, a 613.67% increase from fiscal 2022.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 3.56K shares, a 95.38% decline from fiscal 2021.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 77.15K shares, a 177.70% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 38.43K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 44.30K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | 1.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 44.43K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | 37.22K shares 10-Q · filed 2024-05-10 | 52.73K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | 5.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 25.43K shares 10-K · filed 2026-03-25 |
| 2023-09-30 | 127.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 20.91K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | 9.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 21.03K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | 9.92K shares 10-Q · filed 2023-05-11 | 12.33K shares derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | 1.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 3.56K shares 10-K · filed 2025-03-21 |
| 2022-09-30 | 240.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 25.07K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | 810.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 56.53K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | 1.15K shares 10-Q · filed 2022-05-11 | 75.19K shares derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | 22.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | 77.15K shares 10-K · filed 2024-03-22 |
| 2021-09-30 | 31.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 56.31K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | 19.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 44.06K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | 3.12K shares 10-Q · filed 2021-05-14 | 29.62K shares derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | 2.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 27.78K shares 10-K · filed 2023-03-23 |
| 2020-09-30 | 19.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 26.40K shares derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | 5.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | |
| 2020-03-31 | 1.29K shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 635.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 2.53K shares 10-K · filed 2022-03-23 |
| 2018-12-31 | 1.38K shares 10-K · filed 2021-03-25 | |
| 2017-12-31 | 404.00 shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |